Thrv-1268

· Thryv Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Thrv-1268, covering 2025-05-13 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2) [Phase 2, Phase 3]